-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Apellis Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q2 2024.
- Apellis Pharmaceuticals, Inc. Operating Margin for the quarter ending June 30, 2024 was -49.8 %, a 85% increase year-over-year.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2023 was -130 %, a 83.5% increase from 2022.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2022 was -788 %, a 2.15% increase from 2021.
- Apellis Pharmaceuticals, Inc. annual Operating Margin for 2021 was -806 %, a 845% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)